SCHEMBL7078899

SCHEMBL7078899

CCN(C1=C(O)CC(CCc2ccccc2)(C(C)C)OC1=O)c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WRN Q14191 2/20 0.34
GAA P10253 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CHRM2 P08172 2/20 0.31
ADRA2A P08913 2/20 0.31
DRD1 P21728 2/20 0.31
ADRA1A P35348 2/20 0.31
SLC6A3 Q01959 2/20 0.31
MLNR O43193 1/20 0.31
NR1I2 O75469 1/20 0.31
ABCB11 O95342 1/20 0.31
PGR P06401 1/20 0.31
CTSD P07339 1/20 0.31
PGA5 P0DJD9 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
CTSE P14091 1/20 0.31
GABRA1 P14867 1/20 0.31
ADRA2C P18825 1/20 0.31
HTR2A P28223 1/20 0.31
AGTR1 P30556 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6297241 0.95 LMNA (0.34) WRNOPRD1SMN1; SMN2OPRM1LMNA
SCHEMBL7141092 0.92 WRN (0.33) WRNGAAL3MBTL1CHRM2ADRA2A
SCHEMBL6295768 0.90 OPRD1 (0.34) WRNCHRM2ADRA2ADRD1ADRA1A
SCHEMBL7078065 0.90 WRN (0.36) WRNGAAL3MBTL1CHRM2ADRA2A
SCHEMBL6295921 0.89 OPRM1 (0.38) L3MBTL1CTSDOPRD1PDE4DOPRM1
SCHEMBL6297058 0.89 LMNA (0.36) WRNGAAL3MBTL1OPRD1OPRM1
SCHEMBL6295877 0.87 GLI1 (0.34) OPRD1SMN1; SMN2OPRM1LMNA
SCHEMBL6295654 0.87 ESRRG (0.33) SMN1; SMN2LMNA
SCHEMBL7077864 0.87 TRPM8 (0.43) GAAL3MBTL1ADRA2ADRD1ADRA1A
SCHEMBL6295927 0.85 ESR1 (0.36) CHRM2ADRA2ASLC6A3ADORA3ADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030171425-A1 HIV protease inhibitors BOYER FREDERICK EARL (US) 2003-09-11 US claimed
US-6512006-B1 Novel 3-position Nitrogen substituted 6,6- disubstituted-5, 6-dihydropyrones and related compounds possess antiviral properties WARNER-LAMBERT COMPANY 2003-01-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030171425-A1 HIV protease inhibitors DNPEP, PRSS1, PREP WRN 3729/4885GAA 743/4885L3MBTL1 1238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.